Stay updated on BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page
- ChecktodayChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record content; a Home link is shown in the header.SummaryDifference20%

- Check7 days agoChange DetectedThe page revision changes from v3.6.6 to v3.7.0, indicating an updated version of the page. This appears to be a maintenance/version increment rather than a substantive change to study information.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a minor update to the page revision history.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the page version.SummaryDifference0.1%

- Check50 days agoChange DetectedNew entries show the latest study update date (2026-07-29) and the investigator listed with full credentials (Edward Kim, MD, PhD) along with recent context dates (2026-07-01, 2026-07). Older dates and the plain name Edward Kim were removed (2023-08-22, 2023-08-19, 2023-08), updating the study's authorship and revision history.SummaryDifference0.3%

- Check57 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a minor maintenance update that does not change the trial details presented.SummaryDifference0.1%

Stay in the know with updates to BMS-986205 and Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 and Nivolumab in Liver Cancer Clinical Trial page.